Drug – bio-affecting and body treating compositions – Extract or material containing or obtained from a...
Reexamination Certificate
2005-07-08
2008-08-19
Lilling, Herbert J (Department: 1657)
Drug, bio-affecting and body treating compositions
Extract or material containing or obtained from a...
Reexamination Certificate
active
07413740
ABSTRACT:
Secondary bile acid production inhibitors and cholesterol-lowering agents containing a yeast as the active ingredient.
REFERENCES:
patent: 3995066 (1976-11-01), Muys et al.
patent: 4251519 (1981-02-01), Robbins et al.
patent: 4313934 (1982-02-01), Kitamura et al.
patent: 4530846 (1985-07-01), Nagodawithana et al.
patent: 4716115 (1987-12-01), Gonzalez et al.
patent: 4739046 (1988-04-01), Di Luzio
patent: 4740593 (1988-04-01), Gonzalez et al.
patent: 4891220 (1990-01-01), Donzis
patent: 5622843 (1997-04-01), Day et al.
patent: 5679557 (1997-10-01), Ito et al.
patent: 5811293 (1998-09-01), Furukawa et al.
patent: 6284243 (2001-09-01), Masuyama et al.
patent: 462021 (1991-12-01), None
patent: 50-68867 (1975-06-01), None
patent: 60-94077 (1985-05-01), None
patent: 60-251857 (1985-12-01), None
patent: 62-58987 (1987-03-01), None
patent: 2-286057 (1990-11-01), None
patent: 3-30667 (1991-02-01), None
patent: 04-049243 (1992-02-01), None
patent: 5-211859 (1993-08-01), None
patent: 6-62836 (1994-03-01), None
patent: 8-298982 (1996-11-01), None
patent: 9-23848 (1997-01-01), None
patent: 9-107919 (1997-04-01), None
patent: WO 92/13896 (1992-08-01), None
patent: WO 96/28476 (1996-09-01), None
E. G. Offenbacher, et al., Diabetes, vol. 29, pp. 919-925, “Beneficial Effect of Chromium-Rich Yeast on Glucose Tolerance and Blood Lipids in Elderly Subjects”, Nov. 1980.
E. G. Offenbacher, et al., The American Journal of Clinical Nutrition, vol. 42, No. 3, pp. 454-461, “The Effects of Inorganic Chromium and Brewer's Yeast on Glucose Tolerance, Plasma Lipids, and Plasma Chromium in Elderly Subjects1-4”, Sep. 1985.
A. T. Hostmark, et al., The Journal of Nutrition, vol. 109, No. 6, pp. 1073-1078, “Plasma Lipid and Lipoprotein Responses of Rats to Starch and Sucrose Diets With and Without Brewer's Yeast1”, 1978.
J. DeAbreu, et al., Archivos Latino Americanos De Nutricion, vol. 44, No. 1, pp. 18-22, “Effect of Addition of Brewer's Yeast to Soy Protein and Casein on Plasma Cholesterol Levels of Rabbits”, 1994.
S. Cho, et al., Bulletin of the Faculty of Home Life Science, Fukuoka Women's University, vol. 16, pp. 65-69, “Effect of Polysaccharide Produced byBacillus nattoor Alcohol Extract of Yeast on the Lipid Metabolism of Rats”, Sep. 30, 1984.
T. Kishida, Journal of Japanese Society of Food and Nutrition, vol. 26, pp. 371-375, “On the Serum Cholesterol-Lowering Effect ofSaccharomyces cerevisiaeLiquid Culture”, 1973.
T. Narisawa, et al., Journal of the National Cancer Institute, vol. 53, No. 4, pp. 1093-1097, “Promoting Effect of Bile Acids on Colon Carcinogenesis After Intrarectal Instillation of N-Methyl-N′-Nitro-N-Nitrosoguanidine in Rats1.2”, Oct. 1974.
H. Tsuda, et al., Gann, vol. 75, No. 10., pp. 871-875, “Promotive Effect of Primary and Secondary Bile Acids on the Induction of γ-Glutamyl Transpeptidase-Positive Liver Cell Foci as a Possible Endogenous Factor for Hetatocarcinogenesis in Rats”, Oct. 1984.
T. Makino, et al., J. Natl. Cancer Inst., vol. 76, No. 5, pp. 967-975, “Effects of Phenobarbital and Secondary Bile Acids on Liver, Gallblader, and Pancreas Carcinogenesis Initiated by N-Nitrosobis(2-Hydroxypropyl)Amine in Hamsters1.2”, May 1986.
B. S. Reddy, et al., Cancer Research, vol. 37, pp. 3238-3242, “Promoting Effect of Bile Acids in Colon Carcinogenesis in Germ-Free and Conventional F344 Rats1”, Sep. 1977.
S. N. Marcus, et al., Gut, vol. 29, No. 4, pp. 522-533, “Deoxycholic Acid and the Pathogenesis of Gall Stones”, Apr. 1988.
T. S. Low-Beer, et al., The Lancet, vol. 2, No. 8099, pp. 1063-1065, “Colonic Bacterial Activity, Biliary Cholesterol Saturation, and Pathogenesis of Gallstones”, Nov. 18, 1978.
A. Roda, et al., Journal of Pharmaceutical Sciences, vol. 81, No. 3, pp. 237-240, “Effect of Basic Cholane Derivatives on Intestinal Cholic Acid Metabolism: In Vitro and In Vivo Activity,” Mar. 1992.
F. M. Nagengast, et al., European Journal of Clinical Investigation, vol. 18, pp. 56-61, “Inhibition of Secondary Bile Acid Formation in the Large Intestine by Lactulose in Healthy Subjects of Two Different Age Groups”, 1988.
J. W. Lampe, et al., Gut, vol. 34, pp. 531-536, “Sex Differences in Colonic Function: A Randomised Trial”, 1993.
J. Seikagaku, 1stPrinting, pp. 804-805, “Biosynthesis of Bile Acid”, 1984 (with English translation).
Kazutomo Imahori et al., ed.: “Seikagaku Jiten” Kabushiki Kaisha Tokyo Kagaku Doujin (1st printing in 1984) p. 736 “biosynthesis of bile acid”.
Patent Abstracts of Japan, JP 62-016424, Jan. 24, 1987.
Patent Abstracts of Japan, JP 62-129223, Jun. 11, 1987.
Patent Abstracts of Japan, JP 09-077674, Mar. 25, 1997.
Itoh Masahiko
Ohishi Kenji
Sawada Haruji
Wada Yasue
Watanabe Tunekazu
Kabushiki Kaisha Yakul't Honsha
Lilling Herbert J
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Cholesterol-lowering agents, secondary bile acid production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholesterol-lowering agents, secondary bile acid production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol-lowering agents, secondary bile acid production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4002858